The global Semi-Solid Dosage Form market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents鈥� wealth and the improvement of health awareness will drive the demand for medicines.
The report includes an overview of the development of the Semi-Solid Dosage Form industry chain, the market status of Skin (Ointments, Gels), Nasal Cavity (Ointments, Gels), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Semi-Solid Dosage Form.
Regionally, the report analyzes the Semi-Solid Dosage Form markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Semi-Solid Dosage Form market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Semi-Solid Dosage Form market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Semi-Solid Dosage Form industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Ointments, Gels).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Semi-Solid Dosage Form market.
Regional Analysis: The report involves examining the Semi-Solid Dosage Form market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Semi-Solid Dosage Form market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Semi-Solid Dosage Form:
Company Analysis: Report covers individual Semi-Solid Dosage Form manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Semi-Solid Dosage Form This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Skin, Nasal Cavity).
Technology Analysis: Report covers specific technologies relevant to Semi-Solid Dosage Form. It assesses the current state, advancements, and potential future developments in Semi-Solid Dosage Form areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Semi-Solid Dosage Form market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Semi-Solid Dosage Form market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Ointments
Gels
Others
Market segment by Application
Skin
Nasal Cavity
Vaginal Cavity
Rectal Cavity
Others
Major players covered
Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestl茅 SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan plc
Biofrontera, Inc.
Crown Laboratories Inc.
Akorn Inc. (US)
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics Inc.
Mylan N.V.
Encore Dermatology, Inc.
LEO Pharma
Almirall, S.A
Aclaris Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd.
Teligent Pharma
Perrigo Pharma
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Semi-Solid Dosage Form product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Semi-Solid Dosage Form, with price, sales, revenue and global market share of Semi-Solid Dosage Form from 2019 to 2024.
Chapter 3, the Semi-Solid Dosage Form competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Semi-Solid Dosage Form breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Semi-Solid Dosage Form market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Semi-Solid Dosage Form.
Chapter 14 and 15, to describe Semi-Solid Dosage Form sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 Market Overview
1.1 Product Overview and Scope of Semi-Solid Dosage Form
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Semi-Solid Dosage Form Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Ointments
1.3.3 Gels
1.3.4 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Semi-Solid Dosage Form Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Skin
1.4.3 Nasal Cavity
1.4.4 Vaginal Cavity
1.4.5 Rectal Cavity
1.4.6 Others
1.5 Global Semi-Solid Dosage Form Market Size & Forecast
1.5.1 Global Semi-Solid Dosage Form Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Semi-Solid Dosage Form Sales Quantity (2019-2030)
1.5.3 Global Semi-Solid Dosage Form Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Johnson & Johnson
2.1.1 Johnson & Johnson Details
2.1.2 Johnson & Johnson Major Business
2.1.3 Johnson & Johnson Semi-Solid Dosage Form Product and Services
2.1.4 Johnson & Johnson Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Johnson & Johnson Recent Developments/Updates
2.2 Merck & Co
2.2.1 Merck & Co Details
2.2.2 Merck & Co Major Business
2.2.3 Merck & Co Semi-Solid Dosage Form Product and Services
2.2.4 Merck & Co Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Merck & Co Recent Developments/Updates
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Semi-Solid Dosage Form Product and Services
2.3.4 Bayer AG Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bayer AG Recent Developments/Updates
2.4 Hisamitsu Pharmaceutical
2.4.1 Hisamitsu Pharmaceutical Details
2.4.2 Hisamitsu Pharmaceutical Major Business
2.4.3 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Product and Services
2.4.4 Hisamitsu Pharmaceutical Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
2.5 Glenmark Pharmaceuticals
2.5.1 Glenmark Pharmaceuticals Details
2.5.2 Glenmark Pharmaceuticals Major Business
2.5.3 Glenmark Pharmaceuticals Semi-Solid Dosage Form Product and Services
2.5.4 Glenmark Pharmaceuticals Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Glenmark Pharmaceuticals Recent Developments/Updates
2.6 Cipla Ltd
2.6.1 Cipla Ltd Details
2.6.2 Cipla Ltd Major Business
2.6.3 Cipla Ltd Semi-Solid Dosage Form Product and Services
2.6.4 Cipla Ltd Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Cipla Ltd Recent Developments/Updates
2.7 Nestl茅 SA
2.7.1 Nestl茅 SA Details
2.7.2 Nestl茅 SA Major Business
2.7.3 Nestl茅 SA Semi-Solid Dosage Form Product and Services
2.7.4 Nestl茅 SA Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Nestl茅 SA Recent Developments/Updates
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business
2.8.3 Novartis AG Semi-Solid Dosage Form Product and Services
2.8.4 Novartis AG Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novartis AG Recent Developments/Updates
2.9 GlaxoSmithKline plc
2.9.1 GlaxoSmithKline plc Details
2.9.2 GlaxoSmithKline plc Major Business
2.9.3 GlaxoSmithKline plc Semi-Solid Dosage Form Product and Services
2.9.4 GlaxoSmithKline plc Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 GlaxoSmithKline plc Recent Developments/Updates
2.10 Bausch Health Companies
2.10.1 Bausch Health Companies Details
2.10.2 Bausch Health Companies Major Business
2.10.3 Bausch Health Companies Semi-Solid Dosage Form Product and Services
2.10.4 Bausch Health Companies Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Bausch Health Companies Recent Developments/Updates
2.11 Allergan plc
2.11.1 Allergan plc Details
2.11.2 Allergan plc Major Business
2.11.3 Allergan plc Semi-Solid Dosage Form Product and Services
2.11.4 Allergan plc Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Allergan plc Recent Developments/Updates
2.12 Biofrontera, Inc.
2.12.1 Biofrontera, Inc. Details
2.12.2 Biofrontera, Inc. Major Business
2.12.3 Biofrontera, Inc. Semi-Solid Dosage Form Product and Services
2.12.4 Biofrontera, Inc. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Biofrontera, Inc. Recent Developments/Updates
2.13 Crown Laboratories Inc.
2.13.1 Crown Laboratories Inc. Details
2.13.2 Crown Laboratories Inc. Major Business
2.13.3 Crown Laboratories Inc. Semi-Solid Dosage Form Product and Services
2.13.4 Crown Laboratories Inc. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Crown Laboratories Inc. Recent Developments/Updates
2.14 Akorn Inc. (US)
2.14.1 Akorn Inc. (US) Details
2.14.2 Akorn Inc. (US) Major Business
2.14.3 Akorn Inc. (US) Semi-Solid Dosage Form Product and Services
2.14.4 Akorn Inc. (US) Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Akorn Inc. (US) Recent Developments/Updates
2.15 Ingenus Pharmaceuticals
2.15.1 Ingenus Pharmaceuticals Details
2.15.2 Ingenus Pharmaceuticals Major Business
2.15.3 Ingenus Pharmaceuticals Semi-Solid Dosage Form Product and Services
2.15.4 Ingenus Pharmaceuticals Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Ingenus Pharmaceuticals Recent Developments/Updates
2.16 Sun Pharmaceuticals
2.16.1 Sun Pharmaceuticals Details
2.16.2 Sun Pharmaceuticals Major Business
2.16.3 Sun Pharmaceuticals Semi-Solid Dosage Form Product and Services
2.16.4 Sun Pharmaceuticals Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Sun Pharmaceuticals Recent Developments/Updates
2.17 Crescita Therapeutics Inc.
2.17.1 Crescita Therapeutics Inc. Details
2.17.2 Crescita Therapeutics Inc. Major Business
2.17.3 Crescita Therapeutics Inc. Semi-Solid Dosage Form Product and Services
2.17.4 Crescita Therapeutics Inc. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Crescita Therapeutics Inc. Recent Developments/Updates
2.18 Mylan N.V.
2.18.1 Mylan N.V. Details
2.18.2 Mylan N.V. Major Business
2.18.3 Mylan N.V. Semi-Solid Dosage Form Product and Services
2.18.4 Mylan N.V. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Mylan N.V. Recent Developments/Updates
2.19 Encore Dermatology, Inc.
2.19.1 Encore Dermatology, Inc. Details
2.19.2 Encore Dermatology, Inc. Major Business
2.19.3 Encore Dermatology, Inc. Semi-Solid Dosage Form Product and Services
2.19.4 Encore Dermatology, Inc. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Encore Dermatology, Inc. Recent Developments/Updates
2.20 LEO Pharma
2.20.1 LEO Pharma Details
2.20.2 LEO Pharma Major Business
2.20.3 LEO Pharma Semi-Solid Dosage Form Product and Services
2.20.4 LEO Pharma Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 LEO Pharma Recent Developments/Updates
2.21 Almirall, S.A
2.21.1 Almirall, S.A Details
2.21.2 Almirall, S.A Major Business
2.21.3 Almirall, S.A Semi-Solid Dosage Form Product and Services
2.21.4 Almirall, S.A Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 Almirall, S.A Recent Developments/Updates
2.22 Aclaris Therapeutics, Inc.
2.22.1 Aclaris Therapeutics, Inc. Details
2.22.2 Aclaris Therapeutics, Inc. Major Business
2.22.3 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Product and Services
2.22.4 Aclaris Therapeutics, Inc. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Aclaris Therapeutics, Inc. Recent Developments/Updates
2.23 Taro Pharmaceutical Industries Ltd.
2.23.1 Taro Pharmaceutical Industries Ltd. Details
2.23.2 Taro Pharmaceutical Industries Ltd. Major Business
2.23.3 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Product and Services
2.23.4 Taro Pharmaceutical Industries Ltd. Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.23.5 Taro Pharmaceutical Industries Ltd. Recent Developments/Updates
2.24 Teligent Pharma
2.24.1 Teligent Pharma Details
2.24.2 Teligent Pharma Major Business
2.24.3 Teligent Pharma Semi-Solid Dosage Form Product and Services
2.24.4 Teligent Pharma Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.24.5 Teligent Pharma Recent Developments/Updates
2.25 Perrigo Pharma
2.25.1 Perrigo Pharma Details
2.25.2 Perrigo Pharma Major Business
2.25.3 Perrigo Pharma Semi-Solid Dosage Form Product and Services
2.25.4 Perrigo Pharma Semi-Solid Dosage Form Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.25.5 Perrigo Pharma Recent Developments/Updates
3 Competitive Environment: Semi-Solid Dosage Form by Manufacturer
3.1 Global Semi-Solid Dosage Form Sales Quantity by Manufacturer (2019-2024)
3.2 Global Semi-Solid Dosage Form Revenue by Manufacturer (2019-2024)
3.3 Global Semi-Solid Dosage Form Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Semi-Solid Dosage Form by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Semi-Solid Dosage Form Manufacturer Market Share in 2023
3.4.2 Top 6 Semi-Solid Dosage Form Manufacturer Market Share in 2023
3.5 Semi-Solid Dosage Form Market: Overall Company Footprint Analysis
3.5.1 Semi-Solid Dosage Form Market: Region Footprint
3.5.2 Semi-Solid Dosage Form Market: Company Product Type Footprint
3.5.3 Semi-Solid Dosage Form Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Semi-Solid Dosage Form Market Size by Region
4.1.1 Global Semi-Solid Dosage Form Sales Quantity by Region (2019-2030)
4.1.2 Global Semi-Solid Dosage Form Consumption Value by Region (2019-2030)
4.1.3 Global Semi-Solid Dosage Form Average Price by Region (2019-2030)
4.2 North America Semi-Solid Dosage Form Consumption Value (2019-2030)
4.3 Europe Semi-Solid Dosage Form Consumption Value (2019-2030)
4.4 Asia-Pacific Semi-Solid Dosage Form Consumption Value (2019-2030)
4.5 South America Semi-Solid Dosage Form Consumption Value (2019-2030)
4.6 Middle East and Africa Semi-Solid Dosage Form Consumption Value (2019-2030)
5 Market Segment by Type
5.1 Global Semi-Solid Dosage Form Sales Quantity by Type (2019-2030)
5.2 Global Semi-Solid Dosage Form Consumption Value by Type (2019-2030)
5.3 Global Semi-Solid Dosage Form Average Price by Type (2019-2030)
6 Market Segment by Application
6.1 Global Semi-Solid Dosage Form Sales Quantity by Application (2019-2030)
6.2 Global Semi-Solid Dosage Form Consumption Value by Application (2019-2030)
6.3 Global Semi-Solid Dosage Form Average Price by Application (2019-2030)
7 North America
7.1 North America Semi-Solid Dosage Form Sales Quantity by Type (2019-2030)
7.2 North America Semi-Solid Dosage Form Sales Quantity by Application (2019-2030)
7.3 North America Semi-Solid Dosage Form Market Size by Country
7.3.1 North America Semi-Solid Dosage Form Sales Quantity by Country (2019-2030)
7.3.2 North America Semi-Solid Dosage Form Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
8.1 Europe Semi-Solid Dosage Form Sales Quantity by Type (2019-2030)
8.2 Europe Semi-Solid Dosage Form Sales Quantity by Application (2019-2030)
8.3 Europe Semi-Solid Dosage Form Market Size by Country
8.3.1 Europe Semi-Solid Dosage Form Sales Quantity by Country (2019-2030)
8.3.2 Europe Semi-Solid Dosage Form Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Semi-Solid Dosage Form Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Semi-Solid Dosage Form Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Semi-Solid Dosage Form Market Size by Region
9.3.1 Asia-Pacific Semi-Solid Dosage Form Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Semi-Solid Dosage Form Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
10.1 South America Semi-Solid Dosage Form Sales Quantity by Type (2019-2030)
10.2 South America Semi-Solid Dosage Form Sales Quantity by Application (2019-2030)
10.3 South America Semi-Solid Dosage Form Market Size by Country
10.3.1 South America Semi-Solid Dosage Form Sales Quantity by Country (2019-2030)
10.3.2 South America Semi-Solid Dosage Form Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Semi-Solid Dosage Form Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Semi-Solid Dosage Form Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Semi-Solid Dosage Form Market Size by Country
11.3.1 Middle East & Africa Semi-Solid Dosage Form Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Semi-Solid Dosage Form Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
12.1 Semi-Solid Dosage Form Market Drivers
12.2 Semi-Solid Dosage Form Market Restraints
12.3 Semi-Solid Dosage Form Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Semi-Solid Dosage Form and Key Manufacturers
13.2 Manufacturing Costs Percentage of Semi-Solid Dosage Form
13.3 Semi-Solid Dosage Form Production Process
13.4 Semi-Solid Dosage Form Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Semi-Solid Dosage Form Typical Distributors
14.3 Semi-Solid Dosage Form Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Johnson & Johnson
Merck & Co
Bayer AG
Hisamitsu Pharmaceutical
Glenmark Pharmaceuticals
Cipla Ltd
Nestl茅 SA
Novartis AG
GlaxoSmithKline plc
Bausch Health Companies
Allergan plc
Biofrontera, Inc.
Crown Laboratories Inc.
Akorn Inc. (US)
Ingenus Pharmaceuticals
Sun Pharmaceuticals
Crescita Therapeutics Inc.
Mylan N.V.
Encore Dermatology, Inc.
LEO Pharma
Almirall, S.A
Aclaris Therapeutics, Inc.
Taro Pharmaceutical Industries Ltd.
Teligent Pharma
Perrigo Pharma
听
听
*If Applicable.
